drugset / Trial / NCT06612255
A Study Comparing the Bioavailability of a Taste-masked Delafloxacin Powder for Oral Suspension With the Delafloxacin Tablet in Healthy Adults
Phase 1
Terminated
16 enrolled
Melinta Therapeutics, Inc.
Biomedical Advanced Research and Development Authority · collab
RandomizedSequentialOpen-labelTreatment
Summary
This study will compare the bioavailability of a novel powder for oral suspension formulation of delafloxacin, intended for treatment of community acquired bacterial pneumonia, to that of the licensed delafloxacin oral tablet in healthy adults.
Timeline
- Start
- 2024-06-03
- Primary completion
- 2024-09-11
- Completion
- 2024-09-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Delafloxacin | Small molecule | — | Oral |
Indications
No indication recorded.